Cargando…

Low-Density Granulocytes in Immune-Mediated Inflammatory Diseases

Low-density granulocytes (LDGs), a distinct subset of neutrophils that colocalize with peripheral blood mononuclear cells after density gradient centrifugation, have been observed in many immune-mediated diseases. LDGs are considered highly proinflammatory because of enhanced spontaneous formation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Xin, Wang, Wen-Ming, Jin, Hong-Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820945/ https://www.ncbi.nlm.nih.gov/pubmed/35141336 http://dx.doi.org/10.1155/2022/1622160

Ejemplares similares

The Enigma of Low-Density Granulocytes in Humans: Complexities in the Characterization and Function of LDGs during Disease
por: Seman, Brittany G., et al.
Publicado: (2021)

Characterization of low-density granulocytes in COVID-19
por: Cabrera, Luz E., et al.
Publicado: (2021)

Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD
por: Xie, Kangzhe, et al.
Publicado: (2023)

Low-Density Granulocytes Are Elevated in Mycobacterial Infection and Associated with the Severity of Tuberculosis
por: Deng, Yating, et al.
Publicado: (2016)

Dysregulated low-density granulocyte contributes to early spontaneous abortion
por: Ye, Hongxia, et al.
Publicado: (2023)

Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
por: Martínez, Ana Victoria Carro, et al.
Publicado: (2021)

A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2019)

Indicator of Inflammation and NETosis—Low-Density Granulocytes as a Biomarker of Autoimmune Hepatitis
por: Domerecka, Weronika, et al.
Publicado: (2022)

Peripheral low-density granulocytes after colorectal cancer surgery in predicting recurrence
por: Futoh, Yurie, et al.
Publicado: (2023)

Characterization of a Novel Population of Low-Density Granulocytes Associated with Disease Severity in HIV-1 Infection
por: Cloke, Thomas, et al.
Publicado: (2012)

Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
por: Chen, Xiu-Li, et al.
Publicado: (2020)

Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease
por: Bartneck, Matthias, et al.
Publicado: (2019)

Low Density Granulocytes in ANCA Vasculitis Are Heterogenous and Hypo-Responsive to Anti-Myeloperoxidase Antibodies
por: Ui Mhaonaigh, Aisling, et al.
Publicado: (2019)

Helminth Therapy for Immune-Mediated Inflammatory Diseases: Current and Future Perspectives
por: Shi, Wenjie, et al.
Publicado: (2022)

An Inflammatory Environment: Donor Granulocytes Mediate Endothelial Regeneration Following Transplantation
por: Milsom, Michael D.
Publicado: (2018)

Low-density granulocytes display immature cells with enhanced NET formation in people living with HIV
por: Park, Juwon, et al.
Publicado: (2023)

Granulocytes and Cells of Granulocyte Origin—The Relevant Players in Colorectal Cancer
por: Siemińska, Izabela, et al.
Publicado: (2021)

Mycobacterium tuberculosis Infection Induces Low-Density Granulocyte Generation by Promoting Neutrophil Extracellular Trap Formation via ROS Pathway
por: Su, Rigu, et al.
Publicado: (2019)

Vaccinations in patients with immune-mediated inflammatory diseases
por: Rahier, Jean-François, et al.
Publicado: (2010)

Inflammatory but not apoptotic death of granulocytes citrullinates fibrinogen
por: Blachère, Nathalie E., et al.
Publicado: (2015)

Effects of Anthraquinones on Immune Responses and Inflammatory Diseases
por: Xin, Dandan, et al.
Publicado: (2022)

Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus
por: Rahman, Saifur, et al.
Publicado: (2019)

Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
por: Stockfelt, Marit, et al.
Publicado: (2021)

The role of platelets in immune-mediated inflammatory diseases
por: Scherlinger, Marc, et al.
Publicado: (2023)

Apoptosis of Eosinophil Granulocytes
por: Zustakova, Martina, et al.
Publicado: (2020)

Increased levels of immature and activated low density granulocytes and altered degradation of neutrophil extracellular traps in granulomatosis with polyangiitis
por: Lipka, Spyridon, et al.
Publicado: (2023)

Alteration of Gut Immunity and Microbiome in Mixed Granulocytic Asthma
por: Gu, Bon-Hee, et al.
Publicado: (2022)

Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations
por: Bezzio, Cristina, et al.
Publicado: (2022)

Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
por: Jiang, Yan, et al.
Publicado: (2021)

Cancer risk in immune-mediated inflammatory diseases (IMID)
por: Beyaert, Rudi, et al.
Publicado: (2013)

Tyk2 Targeting in Immune-Mediated Inflammatory Diseases
por: Rusiñol, Lluís, et al.
Publicado: (2023)

Granulocyte-targeted therapies for airway diseases
por: Tavares, Luciana P., et al.
Publicado: (2020)

Low-Density Granulocytes Are a Novel Immunopathological Feature in Both Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Ostendorf, Lennard, et al.
Publicado: (2019)

Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection
por: Brown, Pierre Antoine, et al.
Publicado: (2005)

Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences
por: Pillay, Janesh, et al.
Publicado: (2013)

The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases
por: Țiburcă, Laura, et al.
Publicado: (2022)

Main Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases
por: Gualtierotti, Roberta, et al.
Publicado: (2018)

The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases
por: Anchang, Charles Gwellem, et al.
Publicado: (2021)

Monitoring and Managing Cardiovascular Risk in Immune Mediated Inflammatory Diseases
por: Anyfanti, Panagiota, et al.
Publicado: (2021)

Inflammatory Bowel Disease: Autoimmune or Immune-mediated Pathogenesis?
por: Wen, Zhonghui, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_p73qvos394m91fhjkc9g78grc8